嗜碱性粒细胞增多预示真性红细胞增多症、原发性血小板增多症、原发性骨髓纤维化和无法分类的骨髓增殖性肿瘤患者预后较差。 - Suppr

Suppr

超能文献

Basophilia Predicts Poorer Outcomes in Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis, and Myeloproliferative Neoplasm, Unclassifiable.

作者信息

Yuen Lisa, Gogakos Tasos, Boiocchi Leonardo, Hobbs Gabriela, Hasserjian Robert

机构信息

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Am J Hematol. 2025 Feb;100(2):320-322. doi: 10.1002/ajh.27530. Epub 2024 Nov 22.

DOI:10.1002/ajh.27530

PMID:39578367

Abstract

摘要

相似文献

Basophilia Predicts Poorer Outcomes in Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis, and Myeloproliferative Neoplasm, Unclassifiable.嗜碱性粒细胞增多预示真性红细胞增多症、原发性血小板增多症、原发性骨髓纤维化和无法分类的骨髓增殖性肿瘤患者预后较差。

Am J Hematol. 2025 Feb;100(2):320-322. doi: 10.1002/ajh.27530. Epub 2024 Nov 22.

Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia.真性红细胞增多症、原发性骨髓纤维化和原发性血小板增多症中的细胞遗传学、JAK2和MPL突变

Rev Bras Hematol Hemoter. 2011;33(6):417-24. doi: 10.5581/1516-8484.20110116.

Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.真性红细胞增多症、原发性血小板增多症以及原发性骨髓纤维化伴或不伴JAK2 V617F突变时的巨核细胞形态及临床参数

Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.

[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].[JAK2V617F突变在慢性骨髓增殖性肿瘤患者中的意义]

Orv Hetil. 2011 Nov 6;152(45):1795-803. doi: 10.1556/OH.2011.29226.

Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.骨髓纤维化、原发性血小板增多症和真性红细胞增多症患者自然杀伤（NK）细胞功能受损的定量和功能研究。I. 血小板衍生生长因子在NK细胞毒性缺陷中的潜在作用。

Nat Immun. 1993 May-Jun;12(3):136-51.

CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.四种不同亚型骨髓增殖性肿瘤患者（原发性骨髓纤维化、原发性血小板增多症、真性红细胞增多症和无法分类的骨髓增殖性肿瘤）的CALR、JAK2和MPL突变谱

Am J Clin Pathol. 2015 May;143(5):635-44. doi: 10.1309/AJCPUAAC16LIWZMM.

The role of beta-catenin in chronic myeloproliferative disorders.β-连环蛋白在慢性骨髓增殖性疾病中的作用。

Hum Pathol. 2008 Oct;39(10):1454-8. doi: 10.1016/j.humpath.2008.02.007. Epub 2008 Jul 11.

A phase 1 study of the Janus kinase 2 (JAK2) inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia.一项关于Janus激酶2（JAK2）抑制剂甘托替尼（LY2784544）用于原发性骨髓纤维化、真性红细胞增多症和原发性血小板增多症患者的1期研究。

Leuk Res. 2017 Oct;61:89-95. doi: 10.1016/j.leukres.2017.08.010. Epub 2017 Aug 31.

The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.JAK2 V617F时代真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化的诊断与管理

Clin Adv Hematol Oncol. 2009 May;7(5):334-42.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].慢性骨髓增殖性疾病诊断的新方法——JAK2 突变检测

Orv Hetil. 2006 Nov 12;147(45):2175-9.

引用本文的文献

Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates.真性红细胞增多症和原发性血小板增多症中的嗜碱性粒细胞增多和嗜酸性粒细胞增多：临床、基因型及预后相关性

Ann Hematol. 2025 Jun 14. doi: 10.1007/s00277-025-06422-x.

Shared genetic features inference among hypoxia-ischemia diseases in the presence of heterogenous omics data based on a novel risk assessment method.基于一种新型风险评估方法，在存在异质组学数据的情况下推断缺氧缺血性疾病之间的共享遗传特征。

Front Genet. 2025 Apr 28;16:1587854. doi: 10.3389/fgene.2025.1587854. eCollection 2025.

Basophilia and eosinophilia in primary myelofibrosis: phenotype, genotype, and prognostic correlates.原发性骨髓纤维化中的嗜碱性粒细胞增多和嗜酸性粒细胞增多：表型、基因型及预后相关性

Blood Cancer J. 2025 Apr 21;15(1):72. doi: 10.1038/s41408-025-01285-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验